Match Document Document Title
DE102009052404B4 System and method for screening candidate compounds  
System for screening candidate compounds comprising i) a first type of Lipidmembranvesikeln A containing an optionally predetermined amount of functional channel protein complexes in the lipid...
DE102009045924B4 Method and test system to evaluate the impact of substances on nerve fibers of projection systems  
A method for determining the influence of substances on nerve fibers of projection system comprising: a.) cultivation i.) at least a first tissue sample was isolated from a first region of the...
DE102009045924A1 Analysis of influence of substances on nerve fibers of projection systems comprises culturing e.g. first tissue sample isolated from first region of CNS of animal, adding substance to be examined, determining and analysis of fiber property  
Analysis of the influence of substances on nerve fibers of projection systems, comprises (a) culturing e.g. (i) at least a first tissue sample, which is isolated from a first region of the CNS of...
DE102009048473A1 Method for the detection of microorganisms in a bath with a water-based varnish, comprises transferring a sample in the bath, with a salt in order to coagulate the solid of the varnish and separating the coagulate from the liquid  
The method for the detection of microorganisms in a bath with a water-based varnish, comprises transferring a sample in the bath, with a salt in order to coagulate the solid of the varnish,...
DE102009042160B3 A method for diagnosing and / or predicting the development of neurodegenerative diseases  
The present invention relates to a method for diagnosing and / or predicting the development of neurodegenerative diseases, and includes the steps of a) isolating white blood cells from a blood...
DE102009040716A1 Use of CD154 for the identification and separation of non-regulatory T cells from a mixture with regulatory T cells  
The invention relates to the use of CD154 for the separation of activated conventional T-cells from an activated regulatory T cells (Treg) comprising mixture.
DE102009040716B4 Use of CD154 for the identification and separation of non-regulatory T cells from a mixture with regulatory T cells  
Use of CD154 for the separation of activated conventional T-cells from an activated regulatory T cells (Treg) comprising a mixture of cells for providing a pure cell population of Treg.
DE102009041885A1 Separation of Mesenchymal Stem Cells  
The present invention relates to the use of a binding molecule which binds to CD146 for the isolation and / or identification of stem cells with osteogenic differentiation potential. the invention...
DE102009041885B4 Separation of Mesenchymal Stem Cells  
Use of binding to the cell surface markers CD146 binding molecules for the in vitro isolation and / or identification of mesenchymal stem cells with osteogenic differentiation potential of a...
DE102009038520A1 Method and apparatus for cell samples diagnostics  
The invention relates to a method for diagnosis of cell samples of a cell sample or cell culture. The invention also relates to a computer program product, a data carrier having stored thereon a...
DE102009038520B4 Method and apparatus for cell samples diagnostics  
A method for diagnosis of cell samples of a cell sample or cell culture, characterized in that a) at least one segment of the cell sample or cell culture is detected microscopically video over a...
DE102009039547A1 Evaluating disinfection and/or sterilization process through the determination of resistance of microbiological materials, by arranging indicator objects or samples in the form of carrier substrate on an object carrier of a testing device  
The method for the evaluation of disinfection and/or sterilization process through the determination of resistance of microbiological materials against a disinfection- and/or sterilization medium...
DE102009035502A1 Method and apparatus for detecting the movement and deposition of cells and particles to cell, tissue and implant layers in the simulation of flow conditions  
The task was to capture the movement and accumulation processes in cells and particles in the simulation of flow conditions accurately and completely.According to the movement and accumulation of...
DE112008003471T5 Sample identification device and sample identification method  
Sample identification apparatus comprising: an image input device for inputting image information of a sample; an image display means for displaying the image information to an observer; an area...
DE102008064065B9 dye solution  
Water-based, biocompatible eye membrane dye solution containing at least one dye selected from the group consisting of: triphenylmethane, azo dyes, cyanine dyes and / or natural dyes or mixtures...
DE102009017965A1 A method for the detection of mycorrhizal  
The invention relates to a method for analyzing a sample, the soil and / or plant root tissue may contain, on the content of mycorrhizal fungi, preferably arbuscular mycorrhizal fungi,...
DE102009017965B4 A method for the detection of mycorrhizal  
A method for analyzing a sample comprising plant root tissue, on the content of mycorrhizal fungus comprising the steps of Isolation of total DNA from the sample, Denaturing the total DNA,...
DE102009016075A1 Collecting oral mucosa cells and/or cell fragments from patients, comprises chewing water insoluble, non-digestible chewing mass by the patient, adsorbing oral mucosa skin cells, DNA, RNA/their fragments by chewing mass and separating  
Collecting oral mucosa cells and/or cell fragments from patients (subjects/persons), comprises chewing a water insoluble, non-digestible chewing mass by the person or patients; adsorbing the oral...
DE102009013748A1 Determination of interactions constant antibody portions with Fc gamma receptors  
The invention relates to a novel method for the exact determination of the binding of the Fc-portion of IgG antibodies to Fc-gamma receptors and for the simultaneous examination of the antigen...
DE102009013748B4 Determination of interactions constant antibody portions with Fc gamma receptors  
A recombinant expression vector comprising sequences for the recombinant expression of at least one fusion protein on the surface of a mammalian cell comprising a) an extracellular portion of a...
DE102010012421A1 Detecting microorganisms in sample comprises adding two complementary probes marked, respectively, with fluorescent dye and quencher to the sample, stimulating fluorescent dye and determining emission of fluorescence by the fluorescent dye  
Detecting microorganisms in a sample comprises: (a) providing the sample; (b) adding a first probe marked with a fluorescent dye to the sample, where the probe is specific for detecting the...
DE102009013957B4 Methods and means for detecting the activity of osteoclasts  
Method for determining the resorption activity of osteoclasts comprising the steps of: a.) incubation of osteoclasts with a biomineralized, calcium phosphate-containing matrix obtained by...
DE102009013957A1 Methods and means for detecting the activity of osteoclasts  
The invention relates to a method and means for detecting the resorptive activity of osteoclasts, in particular for use in medicine, as well as in life sciences and pharmaceutical...
DE102009046128A1 Non-invasive method for screening of active agent/formulation against skin aging in vivo, comprises contacting human with agent/formulation, applying adhesive tape to skin and tearing off, extracting the biological material and detecting  
Non-invasive method for screening of active agents and/or formulations against skin aging in vivo, comprises: (a) contacting animals, preferably humans with the active agents to be tested and/or...
DE102009007381A1 Antibiotic peptides  
The invention relates to peptide or peptide derivative of the formulas:Sub1-X1-D2-K3-P4-P5-Y6-L7-P8th-R9-P10-X2-P12-P13-R1 4-X3-I16-Y17-N18-X4-Sub2Sub1-X1-D2-K3-P4-P5-Y6-L7-P8th-R9-P1 0-X2-P12-P13-...
DE102008064065B3 dye solution  
The invention relates to a water-based, non-biocompatible cytotoxic preparation for selective staining of the internal limiting membrane (ILM) and / or epiretinal membranes (EMR) in the human or...
DE102009042418A1 Biogas plant with state control for fermentation  
There is a biogas plant provided in which a status check is performed on the state of fabrication. The state control is based on the investigation of the fermenter contents on gram-positive and...
DE102009011253B3 Selection encoding nucleic acid constructs in the absence of frameshift mutations  
The present invention relates to a method for the determination of frameshift mutations in the coding nucleic acid sequences.
DE102010004428B4 Investigation procedure / screening methods involving live cells or live cell systems  
The invention relates to screening methods or search method using libraries of mixtures. According to a search method is proposed according to an optimally effective single-substance mixture,...
DE102010004428A1 Screening method under inclusion of living cells or living cell systems comprises providing different individual substance mixtures of a mixture comprising e.g. Echinacea pallida radix, and contacting the mixture with the living cells  
Screening method under the inclusion of living cells or living cell systems comprises providing at least 1000 different individual substance mixtures of a mixture of Visci albi herba, Echinacea...
DE102009043486A1 Cosmetic use of an active agent or active agent mixture, obtained from e.g. Clintonia borealis or Punica granatum, for preventing and/or inhibiting the effect (i.e. non-pathological effect) of psychoemotional stress on the hair  
Cosmetic use of an active agent or active agent mixture (obtained from plants) for preventing and/or inhibiting the effect of psychoemotional stress on the hair is claimed. An independent claim is...
DE102008062789A1 Evaluating the qualities of egg cells, comprises analyzing follicular fluid of the egg cells to be evaluated, and applying the analyzed results for the evaluation of the individual qualities  
The process comprises analyzing follicular fluid of the egg cells to be evaluated, and applying the analyzed results for the evaluation of the individual qualities. The follicular fluid of the egg...
DE102008058984B4 Optimizing therapy for cancer patients by testing of therapeutic combinations using in vitro tests (SenRes test)  
Currently there is no diagnostic that can evaluate different treatment options for a patient in a test system. In particular, the effects of different nutrient rates and oxygen rates (modified by...
DE102008058984A1 Determining an effective or ineffective chemotherapeutic drugs for patients by individual in vitro testing of live tumor cells before or during therapy, where the drugs are further tested in presence of e.g. oxygen deficiency and glucose  
Determination of effective or ineffective chemotherapeutic drugs (single or in combination) for patients by individual in vitro testing of live tumor cells, before or during the therapy, where the...
DE102008056584B4 Method and apparatus for treatment of objects  
A process for treatment of objects, namely cytological and / or histological specimens, comprising the steps of: Presetting of a compliance program, comprising a plurality of treatment parameters,...
DE102008056584A1 Treating cytological/histological specimens involves introducing specimens based on predetermined treatment program into treatment stations, determining process data time and number of specimens; evaluating and optimizing treatment program  
Treating cytological and histological specimens involves predetermining treatment program comprising multiple treatment parameters; introducing specimens in accordance with the predetermined...
DE102008056583A1 Determining reagent quality in device for treating cytological/histological specimen involves transferring and treating carrier element having test material according to predefined sequence in treatment stations and evaluating test material  
Determining reagent quality in a device having treatment stations (3) for the treatment of at least one of cytological and histological specimen involves providing a carrier element (8) that...
DE102008056583B4 Method and apparatus for determining the quality of reagents  
Procedure for determining the quality reagents for devices with several treatment stations for treatment of objects, comprising the steps of: a) providing a carrier member (8), which is equipped...
DE102009000931B4 A method for determining the quality of the roofing the intended Reet and to test methods for prophylactic Reetschutz  
A method for determining the quality of reed, characterized in that thatch material with ligninolytic fungi of one or more different strains and / or with conditioned media such fungi or fungal...
DE102009000931A1 A method for determining the quality of the roofing the intended Reet and to test methods for prophylactic Reetschutz  
The invention relates to a method for determining the quality of thatch and a method for testing of methods for prophylactic Reetschutz.It is envisaged that thatch material is contacted and...
DE102008053270A1 Apparatus and method for analyzing cells  
The invention provides a carrier substrate for non-specific immobilization of living bacterial and / or eukaryotic cells ready, in particular animal cells that may be present as single cells, cell...
DE102008056277A1 Sensor for electrophysiological investigation in living cells, comprises electrodes, which are formed in a row-or matrix arrangement on the surface of an electrically isolated substrate and are electrically isolated from one another  
The sensor comprises electrodes (5), which are formed in a row-or matrix arrangement on the surface of an electrically isolated substrate (1) and are electrically isolated from one another through...
DE102008056277B4 Sensor for electrophysiological investigations on living cells, and methods for its preparation  
Sensor for electrophysiological studies on living cells, in which electrodes in a row or matrix array formed on the surface of an electrically insulating substrate and insulated from each other...
DE102008050702A1 ChemBioNet component analysis using a stable cell-based TetR-KRAB-luciferase detection system (TIS 10 cells)  
The invention relates to the use of gene constructs under the regulation of promoter constructs containing in cis acting elements that contain binding sites for the tetracycline repressor protein...
DE102008047128A1 Using cis-imidazolines, in particular Nutlinen, for the treatment of chemoresistant cancer  
The present invention relates to a pharmaceutical composition comprising at least one one or more ABC transporters retardant cis-imidazoline, especially Nutlin, can be transported from a cancer...
DE102009026285A1 Method of screening for pathogens  
It is a method of screening reveals the presence of MRSA in a subject, the method comprising the steps of:(A) obtaining an appropriate sample from the subject using a swab or other suitable unit...
DE102008029999A1 PCR-supported method for differential detection of physiological condition of cells comprises achieving the differentiation through the selection of suitable PCR primers for amplification of a section of a specific target sequence  
The PCR-supported method for differential detection of physiological condition of cells comprises achieving the differentiation through the selection of suitable PCR primers for amplification of a...
DE102008002978A1 Identifying species of Methylobacterium, comprises preparing crude extract from methylobacteria, amplifying 16S ribosomal RNA, carrying out restriction digest, analyzing restriction fragment, detecting restriction pattern and comparing  
Identifying different species of genus Methylobacterium, comprises: (a) preparing a crude extract from suspension of methylobacteria; (b) amplifying 16S rRNA (rRNA) gene by PCR; (c) carrying out...
DE102008002978B4 A method for differentiation of different species of the genus Methylobacterium  
A method of identifying various species of the genus Methylobacterium, comprising the following reaction steps: • preparation of a crude extract (RE) of a suspension of Methylobakterien (Rs1 to...
DE102008044911B3 The method and means of activation of memory B lymphocytes  
The invention relates to a method and means for the activation of memory B lymphocytes, in particular for use in immunological research and in medicine. In the inventive method, the cells are...